Atara Biotherapeutics Inc (NASDAQ:ATRA)

Delayed Data
As of Dec 07
 +0.0357 / +5.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Atara Biotherapeutics Inc have a median target of 4.80, with a high estimate of 28.00 and a low estimate of 0.50. The median estimate represents a +590.05% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Atara Biotherapeutics Inc. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.60%
Growthannually -11.75%


Growthquarterly 133.13%
Growthannually -78.72%
Key to the earnings and sales forecast charts.